Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-17 Purchase |
2021-12-21 8:39 pm |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner |
400 | $6.5858 | $2,634 | 8,017,241 (Indirect) |
View |
| 2021-12-14 Purchase |
2021-12-16 11:37 am |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner |
412 | $5.895 | $2,429 | 8,016,841 (Indirect) |
View |
| 2021-12-03 Purchase |
2021-12-03 7:58 pm |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner |
4,500 | $5.93 | $26,685 | 8,016,429 (Indirect) |
View |
| 2021-12-02 Purchase |
2021-12-03 11:16 am |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation Response 10% Owner |
13,836 | $5.3 | $73,331 | 8,011,929 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-07 Option Award |
2022-02-07 4:07 pm |
2022-04-01 2027-01-31 |
Anebulo Pharmaceuticals Inc. | ANEB | ALLEN SIMON Chief Executive Officer |
625,000 | $0 | 625,000 (Direct) |
View |
| 2021-05-06 Option Award(A) |
2021-05-17 9:47 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW Fund LP See Explanation of Responses 10% Owner |
714,250 | $7 | 7,998,093 (Indirect) |
View |
| 2021-05-06 Option Award |
2021-05-07 7:23 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP See Explanation of Responses 10% Owner |
714,286 | $7 | 7,998,129 (Indirect) |
View |
Ownership |
2021-05-06 8:47 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director |
0 | $0 | 82,290 (Direct) |
View |
Ownership |
2021-05-06 8:45 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Aryeh Jason Director |
0 | $0 | 82,290 (Direct) |
View |
Ownership |
2021-05-06 8:41 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Schneeberger Daniel Chief Executive Officer |
0 | $0 | 982,500 (Direct) |
View |
Ownership |
2021-05-06 8:39 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | English Aron R. 22NW LP See Explanation of Response 10% Owner |
0 | $0 | 7,366,133 (Indirect) |
View |
Ownership |
2021-05-06 8:37 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Kupchyk Areta Director |
0 | $0 | 82,290 (Direct) |
View |
Ownership |
2021-05-06 8:12 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Lin Kenneth Director |
0 | $0 | 82,290 (Direct) |
View |
Ownership |
2021-05-06 8:08 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Lawler Joseph F. Director |
0 | $0 | 12,082,290 (Direct) |
View |